609
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluations

Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?

, MD PhD & , MD PhD
Pages 2249-2261 | Published online: 26 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vivencio Barrios & Carlos Escobar. (2014) Which thiazide to choose as add-on therapy for hypertension?. Integrated Blood Pressure Control 7, pages 35-47.
Read now

Articles from other publishers (4)

Marie Hjermitslev, Daniela G. Grimm, Markus Wehland, Ulf Simonsen & Marcus Krüger. (2017) Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension. Basic & Clinical Pharmacology & Toxicology 121:4, pages 225-233.
Crossref
M. Peng, S. Li, J. Wu, Y. Guo, S. Cao & Y. Zhao. (2017) Fragmentation studies of sartans by electrospray ionization mass spectrometry. Journal of Mass Spectrometry 52:9, pages 591-596.
Crossref
Santosh Kumar Puttrevu, Rachumallu Ramakrishna, Manisha Bhateria, Moon Jain, Kashif Hanif & Rabi Sankar Bhatta. (2017) Pharmacokinetic-pharmacodynamic modeling of the antihypertensive interaction between azilsartan medoxomil and chlorthalidone in spontaneously hypertensive rats. Naunyn-Schmiedeberg's Archives of Pharmacology 390:5, pages 457-470.
Crossref
Anselm K. Gitt, Peter Bramlage, Sebastian A. Potthoff, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Martina Ehmen, Taoufik Ouarrak, Jochen Senges & Roland E. Schmieder. (2016) Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry. BMC Cardiovascular Disorders 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.